In summary, our findings underscore the multifaceted role of APOE ε4, influencing both cognitive impairment and NPS likely through partially distinct mechanisms, and suggest future research should investigate APOE-related mechanisms and therapeutic targets to better understand and manage neuropsychiatric symptoms in MCI and ADRD. Here, APOE is linked to Cognitive impairment.